Human Genome Sciences Trades Up 4% on Q4 Results

Human Genome Sciences HGSI released its Q4 earnings results after the closing bell on Monday. The Rockville, Maryland based biotech firm reported a Q4 loss of $0.41 on an earnings per share basis. This compared to analysts consensus EPS estimates which called for a loss of $0.43. Revenues for the quarter were $45.50 million compared to Street consensus of $42.65 million. In Monday's after hours trading session, HGSI shares have added 3.57% to $8.70.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsAfter-Hours CenterMovers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!